elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
actinium-225
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Application
keyword
actinium-225
RIS
0.003
(Research Intensity Score)
Papers
591
Top papers
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
2024 · 195 citations
Actinium-225 targeted alpha particle therapy for prostate cancer
2024 · 78 citations
Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides
2023 · 94 citations
Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225 Ac-J591
2023 · 70 citations
Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials
2023 · 98 citations
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA
2020 · 275 citations
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”
2021 · 196 citations
A Meta-Analysis and Meta-Regression of the Efficacy, Toxicity, and Quality of Life Outcomes Following Prostate-Specific Membrane Antigen Radioligand Therapy Utilising Lutetium-177 and Actinium-225 in Metastatic Prostate Cancer
2024 · 35 citations
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis
2025 · 28 citations
Newest papers
Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy
2026 · 4 citations
A rigorous Monte Carlo simulation framework for Actinium-225-PSMA-617 targeted alpha therapy in metastatic castration-resistant prostate cancer: Methodological advancements using MCNP and GATE
2026 · 1 citations
CAIX-targeted α therapy directed against hypoxic tumor cells in combination with immune checkpoint inhibitors in a syngeneic mouse tumor model
2026 · 2 citations
Macropa Scaffold Expansion for Actinium-225 Chelation: A Synthetic Strategy, Labeling Kinetics, and Theoretical Calculations
2026 · 1 citations
Comparative In Vitro Evaluation of Anti-HIV Immunotoxin, Antibody–Drug Conjugate, and Radioimmunoconjugate Targeted by the Same Antibody
2026 · 2 citations
Prostate-specific membrane antigen theranostics in current clinical use
2026
In vitro evaluation of anti-HIV radioimmunoconjugates labeled with astatine-211, thorium-227 and actinium-225
2026 · 2 citations
Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac
2026
PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED THERAPIES IN THE TREATMENT OF PROSTATE CANCER: ADVANCES, EFFICACY, AND FUTURE DIRECTIONS
2026
Browse all papers →
actinium-225's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
actinium-225's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link